MARATTO

article · Frontiers in Veterinary Science

Identification and Characterization of P0 Protein as a Vaccine Candidate Against Babesia divergens, Blood Parasite of Veterinary and Zoonotic Importance

20227 citationsOpen accessKafr el-Sheikh University

Abstract

The molecular identification and antigenic characterization of P0 protein in <i>Babesia divergens</i>, a blood parasite of veterinary and zoonotic importance, were carried out in this study for use in developing subunit vaccines against <i>B. divergens</i> infection. Recombinant protein encoding P0 (BdP0) was developed in <i>Escherichia coli</i>, and its antiserum was generated in mice for further molecular characterization. Anti-rBdP0 serum had a specific interaction with the corresponding legitimate <i>B. divergens</i> protein, as confirmed by Western blotting and indirect fluorescent antibody tests. ELISA was used to assess the immunogenicity of BdP0 in a group of 68 bovine field samples, and significant immunological reactivity was found in 19 and 20 positive samples of rBdp0 and <i>B. divergens</i> lysate, respectively. The <i>in vitro</i> growth of <i>B. divergens</i> cultures treated with anti-rBdP0 serum was significantly inhibited (<i>p</i> < 0.05). Furthermore, after 6 h of incubation with 2 mg/ml anti-rBdP0 serum, the ability of pre-incubated free merozoites to invade bovine erythrocytes was reduced by 59.88%. The obtained data suggest the possible use of rBdP0 as diagnostic antigen and may serve as a vaccine candidate against babesiosis caused by <i>B. divergens</i> either in animal or human.

Research topics

  • Vector-borne infectious diseases
  • Toxin Mechanisms and Immunotoxins
  • Vector-Borne Animal Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3389/fvets.2021.795906

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.